// App-Quantinova.ai

OP0086 : GENE PROFILING REVEALS SPECIFIC MOLECULAR PATHWAYS IN THE PATHOGENESIS OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE IN PRIMARY ANTIPHOSPHOLIPID SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS WITH ANTIPHOSPHOLIPID SYNDROME

Researchers

Presenter

  • P. Ruiz-Limon

Principal Investigators

  • C. Perez-Sanchez

  • S. Messineo

  • M. A. Aguirre

  • R. M. Carretero

  • A. Rodriguez-Ariza

  • N. Barbarroja

  • M. Khamashta

  • E. Collantes

  • M. J. Cuadrado

  • C. Lopez-Pedrera

Medical Centers

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Rheumatology Unit, IMIBIC-Reina Sofia University Hospital, Cordoba, Spain

  • Dipartimento di Scienze della Salute, Universita Magna Graecia di Catanzaro, Catanzaro, Italy

Locations

  • Spain

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Sjogren's syndrome

  • Coronary Artery Disease

  • Venous thrombosis

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Peroxisome proliferator-activated receptor gamma

  • Interleukin-2

  • Tumor necrosis factor

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved